This call funds multinational innovative research projects focused on developing and validating novel cell and gene therapeutics for personalised medicine. It supports a broad range of therapies including somatic cell therapeutics, gene therapeutics, mRNA, nucleic acid-based methods, and extracellular vesicles. The call encourages interdisciplinary collaborations among academia, clinical/public health sectors, and private partners, with projects spanning all disease areas. The process includes pre-proposal and full proposal stages with deadlines in 2027.
Eligible applicants include academia, research institutes, clinical/public health sector teams, private for-profit partners such as SMEs, and private non-profit organizations. Eligibility is subject to the regulations of participating national and regional funding organizations.
